Longer, argued pieces on policy and the questions behind the headlines.
The Mekong River Commission stands as the sole treaty-based organization for the transboundary basin, yet China's absence and internal sovereignty constraints leave the river's ecology vulnerable to uncoordinated upstream development.
India is the third-largest pharmaceutical producer in the world, yet its quality-assurance system is dangerously strained. A new wave of compliance deadlines is forcing a long-delayed reckoning.
India spends more than a lakh crore rupees a year keeping urea artificially cheap. The imbalance it creates has gotten so bad that the government's own Economic Survey is now arguing to undo it.
The question everyone asks is which exam is harder. The question nobody asks is what happens to the person who fails. In China, they likely still get a seat. In India, they get nothing.
